Craft

Fortrea

Stock Price

$17.7

2024-10-29

Market Capitalization

$1.6 B

2024-10-29

Revenue

$2.7 B

FY, 2025

Fortrea Summary

Company Summary

Overview
Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides services across the clinical pharmacology and clinical development spectrum. The Enabling Services segment offers patient access and clinical trial technology solutions to customers specializing in complex randomization and optimization of the trial drug supply process. The company caters to pharmaceutical, biotechnology, and medical device customers.
Type
Public
Status
Active
Founded
2023
HQ
Durham, NC, US | view all locations
Website
https://www.fortrea.com/
Cybersecurity rating
Sectors

Key People

  • Tom Pike

    Tom Pike, President and CEO, Chairman

  • Oren Cohen

    Oren Cohen, Chief Medical Officer & President of Clinical Pharmacology

  • Mark Morais

    Mark Morais, Chief Operating Officer & President of Clinical Services

  • Jill McConnell

    Jill McConnell, Chief Financial Officer

Operating MetricsView all

Locations

3

Jul, 2023

Countries

90

Jul, 2023

Types of Clients Served

3

Jul, 2023

LocationsView all

60 locations detected

  • Durham, NC HQ

    United States

    8 Moore Dr

  • Bannockburn, IL

    United States

    2201 Waukegan Rd

  • Dallas, TX

    United States

    1341 W Mockingbird Ln #200e

  • Daytona Beach, FL

    United States

    1900 Mason Ave #140

  • Lake Mary, FL

    United States

    100 Technology Park #158

  • Madison, WI

    United States

    3402 Kinsman Blvd

and 54 others

Fortrea Financials

Summary Financials

Revenue (Q1, 2026)
$636.5M
Net income (Q1, 2026)
($23.6M)
Cash (Q1, 2026)
$147.5M
EBIT (Q1, 2026)
($3.4M)
Enterprise value
$1.5B

Footer menu